Edicotinib is an investigational compound that acts as a colony-stimulating factor-1 receptor kinase inhibitor. It has been studied in clinical trials for conditions including rheumatoid arthritis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1142363-52-7
Anthralin
pharmaceutical raw material
Capivasertib
pharmaceutical raw material
Ethyl (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate
pharmaceutical raw material
Losartan
pharmaceutical raw material
5-cyano-N-[2-(4,4-dimethylcyclohexen-1-yl)-6-(2,2,6,6-tetramethyloxan-4-yl)-3-pyridinyl]-1H-imidazole-2-carboxamide
BNVPFDRNGHMRJS-UHFFFAOYSA-N
CC1(CCC(=CC1)C2=C(C=CC(=N2)C3CC(OC(C3)(C)C)(C)C)NC(=O)C4=NC=C(N4)C#N)C